When conventional treatments fail to resolve chronic back or neck pain, disc-level structural damage — particularly annular tears — is often an unaddressed root cause. In many patients, standard therapies target symptoms rather than underlying tissue repair. A thorough diagnostic re-evaluation may reveal options that weren’t previously considered, and outcomes vary by individual case.

For many people living with chronic spine pain, the search for relief becomes an exhausting cycle. Physical therapy, chiropractic care, steroid injections, medication — perhaps even surgery — and yet the pain continues. Our clinical team encounters this pattern regularly. Understanding why earlier treatments may have fallen short is often the first step toward identifying a more targeted path forward.

Many acute pain episodes resolve on their own, but a significant portion of patients transition into chronic pain. When the underlying problem is structural disc damage, symptom-management approaches may provide temporary improvement without addressing the source.

Why Conventional Treatments Often Fall Short

Most standard spine treatments are designed to manage symptoms — not repair structural damage. For patients whose chronic pain originates from internal disc disruption, this distinction matters significantly.

Physical Therapy and Chiropractic Care

Physical therapy and chiropractic adjustments play an important role in improving mobility, strengthening supporting musculature, and correcting movement patterns. They remain foundational for rehabilitation and injury prevention. However, when internal disc damage — such as annular tears or significant degeneration — is the underlying driver, these therapies may not reach the structural source of pain directly. Symptomatic improvement is possible, but if the structural issue persists, pain often returns over time.

Medication: Symptom Management Without Structural Repair

Pain relievers, muscle relaxants, and anti-inflammatory medications can reduce discomfort and support daily function. They do not repair damaged disc tissue. Long-term reliance on medication for chronic pain carries risks including side effects and dependency, and may delay more targeted treatment approaches.

Epidural Steroid Injections

Epidural steroid injections (ESIs) aim to reduce nerve-related inflammation and are commonly used for spine pain. A systematic review by the American Academy of Family Physicians found ESIs to be ineffective for chronic low back pain in many cases. While some patients experience short-term relief, effects typically diminish over time, and repeated injections carry cumulative risks without promoting structural tissue repair.

Spinal Decompression Therapy

Non-surgical spinal decompression aims to create negative intradiscal pressure to encourage nutrient flow and repositioning of disc material. Published study results have been mixed. For significant annular tears or advanced disc degeneration, decompression may not address the structural damage underlying chronic pain in many patients.

Understanding the Root Cause: Disc Damage and Annular Tears

Chronic back pain frequently originates from damage within the intervertebral discs — particularly the annulus fibrosus, the tough outer ring that encases the disc. Tears in this layer are painful for two reasons: the annulus contains nerve fibers, and tears allow inner disc material to leak out and irritate surrounding nerves. These tears also destabilize the disc over time, contributing to progressive degeneration.

Standard MRI sequences do not always capture the full extent of annular damage. Patients whose imaging appears relatively unremarkable may still have clinically significant tears driving their pain. This diagnostic gap is a common reason why pain persists even after treatments that seemed appropriate based on initial evaluation.

Learn more about how annular tears contribute to chronic back pain and what repair options exist.

Failed Back Surgery Syndrome

For some patients, spine surgery does not achieve the relief they were hoping for — a condition referred to as Failed Back Surgery Syndrome (FBSS). Published data suggest a meaningful proportion of spinal surgeries do not achieve expected outcomes. Contributing factors include persistent disc pathology, scar tissue formation, or adjacent segment disease — where discs above or below a fused segment experience increased mechanical stress and may degenerate further. Recovery from spinal fusion can extend well beyond initial estimates, and some patients require revision surgery within a decade. For those in this situation, non-surgical regenerative options are worth evaluating before pursuing additional operations.

For further detail, see Failed Back Surgery Syndrome: Causes and Alternatives.

A Different Approach: Regenerative and Biologic Disc Repair

Our clinical team focuses on non-surgical approaches designed to repair damaged disc tissue rather than manage symptoms alone. These treatments are particularly relevant for patients whose pain originates from internal disc disruption and annular tears.

Intra-Annular Fibrin Injection

Intra-annular fibrin injection — also referred to as biologic disc repair or fibrin disc treatment — involves introducing a biologic sealant directly into an annular tear. The fibrin acts as a scaffold that may support the body’s natural repair processes, helping to stabilize the disc and reduce pain generated by the structural damage. This approach targets the source of pain rather than the surrounding inflammatory response.

Published clinical data indicate that many patients who undergo fibrin disc treatment experience meaningful reductions in pain at long-term follow-up; outcomes vary by individual case and diagnosis. In patients with prior failed surgery, some published studies report that a meaningful proportion experienced improved symptoms, though results are not universal and thorough candidacy evaluation is required before treatment.

• May help seal annular tears and reduce disc material leakage
• May contribute to disc stabilization and reduced pain from movement
• Designed to support tissue repair rather than simply dampen inflammation

Expert Take

Intra-annular fibrin injection addresses a category of disc damage that standard imaging often underrepresents and that conventional treatments rarely reach structurally. Candidates are evaluated individually — not every disc condition responds to this approach, and a thorough diagnostic workup is required to determine whether it is appropriate for a given patient.

Platelet-Rich Plasma and Bone Marrow Concentrate

Other regenerative approaches — including Platelet-Rich Plasma (PRP) and Bone Marrow Concentrate (BMC) — may also play a role in certain spine care cases. PRP contains concentrated growth factors derived from the patient’s own blood that may support healing in musculoskeletal tissue. BMC is a more complex preparation that includes cells with potential to contribute to tissue repair. These therapies are evaluated individually depending on diagnosis, degree of disc damage, and patient history. They are sometimes used in conjunction with fibrin disc treatment, depending on clinical findings.

Who May Be a Candidate for Advanced Non-Surgical Options?

Our clinical team evaluates each patient individually. These advanced options are often considered for patients who:

• Have chronic back or neck pain attributed to disc degeneration or annular tears
• Have not found lasting relief through physical therapy, injections, or medication
• Are seeking to avoid or delay spine surgery
• Want treatment that targets the structural source of pain, not just symptoms
• Have been diagnosed with Failed Back Surgery Syndrome and are exploring alternatives to revision surgery

A comprehensive evaluation — including medical history review, advanced imaging interpretation, and physical examination — is necessary to determine whether biologic disc repair options are appropriate for a given patient. Candidates are assessed on an individual basis; not every disc condition qualifies, and the evaluation process is designed to identify who is most likely to benefit.

ValorSpine’s Approach: Precision Diagnostics and Individualized Care

Our clinical team’s approach centers on precise diagnostic evaluation and individualized treatment planning. Standard diagnostics do not always surface the full picture of disc-level pathology. We prioritize identifying specific structural sources of pain — particularly internal annular tears — that may be missed on routine imaging. Treatment plans are built around each patient’s diagnosis, history, and functional goals.

Our aim is not temporary relief, but longer-term structural support and improved function. For patients who have been told surgery is the only remaining option, or whose prior treatments have not provided lasting benefit, a fresh diagnostic evaluation may open paths that weren’t previously visible.

Finding a Path Forward

Chronic back pain does not have to be permanent. When conventional treatments have not worked, it is often because the structural source of pain — such as an annular tear — was not directly addressed. Regenerative options like intra-annular fibrin injection offer a non-surgical pathway for patients whose pain originates from disc damage, with treatment plans tailored to each individual’s clinical profile.

If previous treatments have not provided lasting relief, a comprehensive re-evaluation focused on disc integrity may clarify what has been missed and what options remain available.